Cancer Res (2023) 83 (8_Supplement): LB319.
Cancer Res (2024) 84 (17_Supplement_2): B068.
AbstractFirst-line multiple myeloma treatment has evolved from melphalan–prednisone to quadruplet regimens incorporating proteasome inhibitors, immunomodulatory drugs, anti-CD38 monoclonal antibodies, ...
To help defray the rising costs of initial manuscript screening and publication, the AACR journals levy fees as detailed herein. Authors are required to confirm at the time of submission that they ...
1Department of Gastroenterology, Ajou University School of Medicine, Suwon, Republic of Korea. 2BK21 R&E Initiative for Advanced Precision Medicine, Ajou University School of Medicine, Suwon, Republic ...
1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
1Department of Medical Oncology, Gustave Roussy, Villejuif, France.